Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease
Related Experiment Video
Updated: Apr 12, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Yuan-Hui Liu1, Yong Liu, Ning Tan
1Southern Medical University, Guangzhou, 510515, Guangdong, China.
Insights
Attempting percutaneous coronary intervention for chronic total occlusion in patients with chronic kidney disease may not increase the risk of contrast-induced nephropathy. Careful preventative measures are key to managing this risk in high-risk patients.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Contrast-induced nephropathy (CIN) is a significant complication following percutaneous coronary intervention (PCI).
- Patients with chronic kidney disease (CKD) are at elevated risk for CIN.
- The specific risk of CIN in CKD patients undergoing PCI for chronic total occlusion (CTO) remains understudied.
Purpose of the Study:
- To investigate the incidence and risk of CIN in high-risk CKD patients undergoing PCI for CTO.
- To compare CIN rates among CKD patients undergoing CTO-PCI, non-CTO PCI, and no PCI.
Main Methods:
- A prospective observational study of 515 consecutive CKD patients undergoing PCI.
- Patients were categorized into three groups: attempted CTO-PCI (Group A), non-CTO PCI (Group B), and no PCI (Group C).
- CIN incidence, contrast media dose, hydration volume, and clinical outcomes were analyzed.
Main Results:
- The overall incidence of CIN was 10.68%.
- Group A (CTO-PCI) received a higher contrast media dose (p=0.024).
- No significant difference in CIN incidence (Group A: 9.4%, Group B: 6.7%, Group C: 11.4%; p=0.344) or outcomes was observed between groups after multivariate analysis.
Conclusions:
- Attempting CTO-PCI in CKD patients does not appear to significantly increase CIN risk when appropriate preventative strategies are employed.
- The study highlights the importance of preventative measures in managing CIN risk in this vulnerable population.
- Further research may focus on optimizing preventative protocols for CTO-PCI in CKD patients.
Objectives:
Contrast-induced nephropathy (CIN) has not been systematically studied in high-risk patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).
Methods:
We prospectively observed 515 consecutive patients with CKD undergoing PCI. Patients were divided into three groups: patients who underwent attempted PCI for CTO (group A, n = 85), patients who did not receive PCI for CTO (group B, n = 45) and patients without CTO (group C, n = 385).
Results:
CIN developed in 55 patients (10.68 %). Group A patients received a larger CM dose than group B or group C (p = 0.024). The intravenous hydration volume, age and CIN Mehran score were not significantly different between the three groups. The incidence of CIN was 9.4 % for group A, 6.7 % for group B and 11.4 % for group C (p = 0.344). In-hospital mortality and required renal replacement therapy (p = 0.325) were not significantly different between the groups. Multivariate analysis showed that after adjusting for potential confounding factors, the odds ratio for CIN was 1.03 (p = 0.944) for group A and 0.64 for group B (p = 0.489) compared to group C.
Conclusions:
Attempts to achieve recanalization of CTO in patients with CKD might not increase the risk of CIN if appropriate preventative measures are taken.
Key Points:
• Contrast-induced nephropathy can increase morbidity and mortality • Chronic kidney disease patients are at the greatest risk of CIN • Patients with CKD undergoing CTO-PCI are common • Incidence of CIN has not been reported in CKD patients • CTO-PCI in CKD patients might not increase the risk of CIN.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations

